The transition has officially begun. The President has authorized the General Services Administration (a bureaucratic name if I have ever heard one) to begin the transition process and allow the helpful and oh-so-welcomed formalities of democracy’s power transfer to ensue. All of this happens notwithstanding the flailing legal clouds and blatantly untrue rhetoric President Trump has chosen to create, but, from where I stand, the future for a successful transition looks bright. Democrats consider the procedure’s initiation a moderate victory while some Republicans are just confused about what to do; they don’t mind losing Trump but they do mind losing his base. In between all of this, we explore the general importance of the Dow Jones gains as of recent, and we also examine what a Biden administration could look like from cabinet picks to policy choices. 

Additionally, the future looks bright for a Coronavirus vaccine. Competition among the healthcare companies is increasing and it looks as if we are less than a month away from the first round’s distribution, according to Pfizer. What progress has been made among the major companies, how logistically possible is it for entities to distribute the vaccine to millions of people, and how will the politicking in Washington affect the current efforts to mitigate COVID-19?